Tilray Stock Surges on Strong Q1 Earnings, Cannabis Sector Growth
Tilray (TLRY) shares jumped 12.79% in pre-market trading after reporting fiscal Q1 2026 results that exceeded analyst expectations. The cannabis company posted flat adjusted diluted EPS, outperforming the anticipated -3 cent loss, while revenue climbed 5% year-over-year to $209.5 million—a record Q1 performance.
Market momentum continues with TLRY up 29.32% YTD. CEO Irwin Simon highlighted Optimism around potential U.S. cannabis rescheduling, though formal guidance remains undisclosed. The earnings beat underscores resilient demand in core cannabis markets despite macroeconomic headwinds.